G. Artas Et Al. , "A promising biomarker to distinguish benign and malignant renal tumors: ELABELA," NIGERIAN JOURNAL OF CLINICAL PRACTICE , vol.22, no.3, pp.386-392, 2019
Artas, G. Et Al. 2019. A promising biomarker to distinguish benign and malignant renal tumors: ELABELA. NIGERIAN JOURNAL OF CLINICAL PRACTICE , vol.22, no.3 , 386-392.
Artas, G., Kuloglu, T., Dagli, A. F., Ugur, K., Yardim, M., Aydin, S., ... Artas, H.(2019). A promising biomarker to distinguish benign and malignant renal tumors: ELABELA. NIGERIAN JOURNAL OF CLINICAL PRACTICE , vol.22, no.3, 386-392.
Artas, G. Et Al. "A promising biomarker to distinguish benign and malignant renal tumors: ELABELA," NIGERIAN JOURNAL OF CLINICAL PRACTICE , vol.22, no.3, 386-392, 2019
Artas, G. Et Al. "A promising biomarker to distinguish benign and malignant renal tumors: ELABELA." NIGERIAN JOURNAL OF CLINICAL PRACTICE , vol.22, no.3, pp.386-392, 2019
Artas, G. Et Al. (2019) . "A promising biomarker to distinguish benign and malignant renal tumors: ELABELA." NIGERIAN JOURNAL OF CLINICAL PRACTICE , vol.22, no.3, pp.386-392.
@article{article, author={G. Artas Et Al. }, title={A promising biomarker to distinguish benign and malignant renal tumors: ELABELA}, journal={NIGERIAN JOURNAL OF CLINICAL PRACTICE}, year=2019, pages={386-392} }